Publication

Article

Cardiology Review® Online

October 2007
Volume24
Issue 10

A good night's sleep is heart healthy

Sleep apnea is a serious, potentially life-threatening condition that is underdiagnosed and mostly untreated in African Americans, who are at greater risk due to their higher prevalence of obesity. The repeated cessation of breathing while sleeping due to pharyngeal obstruction contributes to hypertension, heart disease, depression, anxiety, daytime sleepiness, and fatigue. As I become more familiar with the literature, I am now invested in helping to raise awareness among our colleagues so we can better help our patients. By employing good evidence-based medicine we can create dramatic improvements in quality of life.

Perhaps the most scholarly body of knowledge on sleep medicine I have encountered is Chapter 19 of Cardiovascular Disease and Diabetes (McGraw-Hill, 2007), a new book by Association of Black Cardiologist member Luther Clark, MD. The chapter is entitled "Associations of sleep apnea to cardiovascular disease: role of diabetes and metabolic syndrome." The scholarship of the entire work is excellent, but Chapter 19 is particularly well done. Drs Girardin Jean-Louis, Ferdinand Zizi, Luther Clark, and John Kassotis set out the science underlying the case for the recent emphasis on sleep apnea as the next frontier in the reduction and elimination of cardiovascular disease (CVD) and stroke.

Although most individuals with sleep apnea have not received a comprehensive sleep assessment, sleep apnea and CVD morbidity are now conclusively linked and recognized as an independent risk factor. According to Dr Clark, sleep apnea affects as much as 15% of men and 5% of women between the ages of 30 and 60 years. In addition, 82% of men and 93% of women with moderate- to-severe sleep apnea are undiagnosed and untreated. In the clinical setting, more than half of patients with established CVD have sleep apnea.

I urge all cardiologists to learn more about sleep apnea and be sure that patients who are affected are not needlessly suffering from a condition that is very easily diagnosed and treated. With the advent of continuous positive airway pressure machines, effective treatment is readily available.

Related Videos
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.